197 related articles for article (PubMed ID: 37050997)
21. Fetal hyperthyroidism associated with maternal thyroid autoantibodies: A case report.
Kazakou P; Theodora M; Kanaka-Gantenbein C; Zapanti E; Bouza H; Petropoulou C; Daskalakis G; Paschou SA; Anastasiou E
Case Rep Womens Health; 2018 Oct; 20():e00081. PubMed ID: 30294557
[TBL] [Abstract][Full Text] [Related]
22. The Differential Effects of Propylthiouracil and Methimazole as Graves' Disease Treatment on Vascular Atherosclerosis Markers: A Randomized Clinical Trial.
Wisnu W; Alwi I; Nafrialdi N; Harimurti K; Pemayun TGD; Jusman SWA; Santoso DIS; Harahap AR; Suwarto S; Subekti I
Front Endocrinol (Lausanne); 2021; 12():796194. PubMed ID: 34987480
[TBL] [Abstract][Full Text] [Related]
23. Recurrent fetal thyrotoxicosis in a woman with Graves' disease: case report.
Ting MK; Hsu BR; Huang YY; Lin JD; Chen TC
Changgeng Yi Xue Za Zhi; 1999 Sep; 22(3):492-7. PubMed ID: 10584424
[TBL] [Abstract][Full Text] [Related]
24. Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism.
Romaldini JH; Bromberg N; Werner RS; Tanaka LM; Rodrigues HF; Werner MC; Farah CS; Reis LC
J Clin Endocrinol Metab; 1983 Sep; 57(3):563-70. PubMed ID: 6192139
[TBL] [Abstract][Full Text] [Related]
25. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.
Chung YJ; Lee BW; Kim JY; Jung JH; Min YK; Lee MS; Lee MK; Kim KW; Chung JH
Thyroid; 2006 Dec; 16(12):1251-7. PubMed ID: 17199435
[TBL] [Abstract][Full Text] [Related]
26. Significant cardiac disease complicating Graves' disease in previously healthy young adults.
Witczak JK; Ubaysekara N; Ravindran R; Rice S; Yousef Z; Premawardhana LD
Endocrinol Diabetes Metab Case Rep; 2020 Jan; 2020():. PubMed ID: 31967967
[TBL] [Abstract][Full Text] [Related]
27. Unusual clinical course of Graves' thyrotoxicosis and concomitant sarcoidosis: case report and review of literature.
Rodriguez MC; Rani D; Faas FH
Endocr Pract; 2007; 13(2):159-63. PubMed ID: 17490930
[TBL] [Abstract][Full Text] [Related]
28. Differentiation of postpartum Graves' thyrotoxicosis from postpartum destructive thyrotoxicosis using antithyrotropin receptor antibodies and thyroid blood flow.
Ide A; Amino N; Kang S; Yoshioka W; Kudo T; Nishihara E; Ito M; Nakamura H; Miyauchi A
Thyroid; 2014 Jun; 24(6):1027-31. PubMed ID: 24400892
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis and Management of Fetal and Neonatal Thyrotoxicosis.
Bohîlțea RE; Mihai BM; Szini E; Șucaliuc IA; Badiu C
Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676660
[No Abstract] [Full Text] [Related]
30. Foetal and neonatal thyroid disorders.
Radetti G; Zavallone A; Gentili L; Beck-Peccoz P; Bona G
Minerva Pediatr; 2002 Oct; 54(5):383-400. PubMed ID: 12244277
[TBL] [Abstract][Full Text] [Related]
31. The prevalence of transient thyrotoxicosis after antithyroid drug therapy in patients with Graves' disease.
Kubota S; Takata K; Arishima T; Ohye H; Nishihara E; Kudo T; Ito M; Fukata S; Amino N; Miyauchi A
Thyroid; 2008 Jan; 18(1):63-6. PubMed ID: 18302519
[TBL] [Abstract][Full Text] [Related]
32. Very rare case of Graves' disease with resistance to methimazole: a case report and literature review.
Mori Y; Hiromura M; Terasaki M; Kushima H; Ohara M; Fukui T; Takahashi Y; Yamagishi SI
J Int Med Res; 2021 Mar; 49(3):300060521996192. PubMed ID: 33682498
[TBL] [Abstract][Full Text] [Related]
33. Graves' disease in 2.5 years old girl - 6-years-long observation.
Jonak O; Połubok J; Barg E
Pediatr Endocrinol Diabetes Metab; 2016; 22(2):76-79. PubMed ID: 28329777
[TBL] [Abstract][Full Text] [Related]
34. Propylthiouracil induced C-ANCA positive agranulocytosis complicating Graves' thyrotoxicosis in pregnancy.
Finucane FM; O'Connell J; Kinsley BT
Ir J Med Sci; 2008 Mar; 177(1):69-71. PubMed ID: 17611791
[TBL] [Abstract][Full Text] [Related]
35. Characteristics of Patients with Graves' Disease Whose Thyroid Hormone Levels Increase After Substituting Potassium Iodide for Methimazole in the First Trimester of Pregnancy.
Yoshihara A; Noh JY; Watanabe N; Kunii Y; Suzuki M; Matsumoto M; Suzuki N; Hiruma M; Morisaki M; Kawaguchi A; Sugino K; Ito K
Thyroid; 2020 Mar; 30(3):451-456. PubMed ID: 31928169
[No Abstract] [Full Text] [Related]
36. Graves' disease in pregnancy: prospective evaluation of a selective invasive treatment protocol.
Nachum Z; Rakover Y; Weiner E; Shalev E
Am J Obstet Gynecol; 2003 Jul; 189(1):159-65. PubMed ID: 12861156
[TBL] [Abstract][Full Text] [Related]
37. Graves' disease and thymic hyperplasia: the relationship of thymic volume to thyroid function.
Popoveniuc G; Sharma M; Devdhar M; Wexler JA; Carroll NM; Wartofsky L; Burman KD
Thyroid; 2010 Sep; 20(9):1015-8. PubMed ID: 20718680
[TBL] [Abstract][Full Text] [Related]
38. High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease.
Alexander EK; Larsen PR
J Clin Endocrinol Metab; 2002 Mar; 87(3):1073-7. PubMed ID: 11889166
[TBL] [Abstract][Full Text] [Related]
39. Long-Term Antithyroid Drug Treatment of Graves' Disease in Children and Adolescents: A 20-Year Single-Center Experience.
Song A; Kim SJ; Kim MS; Kim J; Kim I; Bae GY; Seo E; Cho YS; Choi JY; Cho SY; Jin DK
Front Endocrinol (Lausanne); 2021; 12():687834. PubMed ID: 34194397
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
